Both in Pharmaceuticals
Cytokinetics vs TG Therapeutics
Over the past year CYTK returned −0.9% and TGTX returned +75.9%; their daily moves had a correlation of 0.25.
CYTK −0.9% TGTX +75.9%Growth of $1, one year, split-adjusted
| Metric | CYTK | TGTX |
|---|---|---|
| Price | $62.99 | $61.18 |
| Market cap | $8.76B | $9.36B |
| Today | −0.51% | +5.34% |
| 1 month | −4.0% | +14.1% |
| 6 months | −0.6% | +80.7% |
| Year to date | −0.9% | +105.2% |
| 1 year | +1.6% | +81.1% |
| Revenue growth (YoY) | −57.1% | +70.3% |
| Gross margin | 90.5% | 82.9% |
| Net margin | −694.4% | 3.2% |
| P/E (TTM) | — | 21.2× |
| Price / sales | 129.4× | 11.7× |
| Net cash | $18.6M | -$193.1M |
| Dividend yield | — | — |
| Volatility (60d) | 33.6% | 36.6% |
| Short % of float | 15.4% | 20.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).